DK0678524T3 - Antistoffer mod oplöselig human fibrin, hybridom, der producerer dem, samt immunassayfremgangsmåde - Google Patents

Antistoffer mod oplöselig human fibrin, hybridom, der producerer dem, samt immunassayfremgangsmåde

Info

Publication number
DK0678524T3
DK0678524T3 DK94931201T DK94931201T DK0678524T3 DK 0678524 T3 DK0678524 T3 DK 0678524T3 DK 94931201 T DK94931201 T DK 94931201T DK 94931201 T DK94931201 T DK 94931201T DK 0678524 T3 DK0678524 T3 DK 0678524T3
Authority
DK
Denmark
Prior art keywords
fibrin
antibodies
soluble human
immunoassay method
hybridoma producing
Prior art date
Application number
DK94931201T
Other languages
Danish (da)
English (en)
Inventor
Gilbu Soe
Isao Kohno
Kimiko Inuzuka
Yumiko Ito
Original Assignee
Mitsubishi Kagaku Iatron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kagaku Iatron Inc filed Critical Mitsubishi Kagaku Iatron Inc
Application granted granted Critical
Publication of DK0678524T3 publication Critical patent/DK0678524T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94931201T 1993-11-02 1994-11-01 Antistoffer mod oplöselig human fibrin, hybridom, der producerer dem, samt immunassayfremgangsmåde DK0678524T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29732593 1993-11-02
PCT/JP1994/001844 WO1995012617A1 (fr) 1993-11-02 1994-11-01 Hybridome d'anticorps anti-fibrine soluble humaine, et procede d'immunodosage

Publications (1)

Publication Number Publication Date
DK0678524T3 true DK0678524T3 (da) 2008-05-26

Family

ID=17845054

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94931201T DK0678524T3 (da) 1993-11-02 1994-11-01 Antistoffer mod oplöselig human fibrin, hybridom, der producerer dem, samt immunassayfremgangsmåde

Country Status (8)

Country Link
US (1) US5821068A (fr)
EP (1) EP0678524B1 (fr)
JP (1) JP3517754B2 (fr)
AT (1) ATE385506T1 (fr)
DE (1) DE69435072T2 (fr)
DK (1) DK0678524T3 (fr)
ES (1) ES2300102T3 (fr)
WO (1) WO1995012617A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0922761B1 (fr) * 1997-06-24 2009-02-18 Nissui Pharmaceutical Co., Ltd. Anticorps monoclonal specifique d'un monomere anti fibrine humaine, son procede d'obtention, hybridomes et procedes relatifs a des immuno-essais
DE19833844B4 (de) * 1998-04-23 2004-09-23 Institut für Klinische Chemie und Hämatologie des Kantons St.Gallen Verwendung von Fibrinmonomer zur Bestimmung des Risikos einer intraoperativen Blutungsneigung
FR2795735B1 (fr) * 1999-07-01 2001-09-07 Univ Toulouse Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
FR2813395B1 (fr) 2000-08-28 2003-01-24 Stago Diagnostica Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques
US20030003515A1 (en) * 2000-12-05 2003-01-02 Farrell David H. Monocloral antibody-based diagnostic assay for gamma fibrinogen
US20030059951A1 (en) * 2001-08-14 2003-03-27 Frushour Susan L.M. Maternal status testing in animals
US6957580B2 (en) * 2004-01-26 2005-10-25 Gyrodata, Incorporated System and method for measurements of depth and velocity of instrumentation within a wellbore
WO2006070776A1 (fr) * 2004-12-28 2006-07-06 Daiichi Pure Chemicals Co., Ltd. Anticorps monoclonal anti-humain dirige contre la fibrine soluble et procede d'essai immunologique utilisant l'anticorps
JP5222521B2 (ja) * 2004-12-28 2013-06-26 積水メディカル株式会社 抗ヒト可溶性フィブリンモノクローナル抗体の製造方法
WO2006118195A1 (fr) * 2005-04-28 2006-11-09 Mitsubishi Kagaku Iatron, Inc. Méthode d'analyse immunologique du produit de dégradation de la plasmine de fibrine stabilisée
US20070141597A1 (en) * 2005-10-25 2007-06-21 Harmon H J Biomimetic Biodetector of Toxins, Viruses, Bacteria, and Biological Factors
FR2900734B1 (fr) * 2006-05-05 2009-03-06 Diagnostica Stago Soc Par Acti Detection des maladies veineuses thromboemboliques par le dosage des d-dimeres et de la fibrine soluble
CN103026231B (zh) * 2010-07-30 2015-06-24 希森美康株式会社 Fdp测定用试剂及试剂盒、以及测定方法
WO2012014997A1 (fr) * 2010-07-30 2012-02-02 シスメックス株式会社 Anticorps monoclonal anti-fdp, réactif de mesure de fdp, kit de réactifs contenant ledit anticorps et méthode de mesure de fdp associé
US8900822B2 (en) 2011-11-21 2014-12-02 Ethicon, Inc. Fibrinogen assay
WO2022159776A1 (fr) * 2021-01-21 2022-07-28 Therini Bio, Inc. Anticorps qui se lient à la fibrine humaine et méthodes d'utilisation
CN119775405B (zh) * 2025-01-22 2025-12-05 北京赛科希德科技股份有限公司 可溶性纤维蛋白sf抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3701812A1 (de) * 1987-01-22 1988-08-04 Max Planck Gesellschaft Fibrinspezifischer antikoerper, verfahren zur seiner herstellung und seine verwendung
NL8801227A (nl) * 1988-05-10 1989-12-01 Tno Antilichamen tegen fibrine; voor de bereiding van de antilichamen te gebruiken immunogeen, werkwijze voor het bepalen van fibrine met de antilichamen en farmaceutisch preparaat op basis van de antilichamen.
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
NL8901102A (nl) * 1989-05-01 1990-12-03 Tno Antilichamen tegen fibrine; voor de bereiding van de antilichamen geschikte immunogene peptiden, werkwijze voor het bepalen van fibrine en farmaceutisch preparaat op basis van de antilichamen.
DE4134833A1 (de) * 1991-09-25 1993-04-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung von fibrin

Also Published As

Publication number Publication date
ES2300102T3 (es) 2008-06-01
EP0678524A4 (fr) 1999-04-21
US5821068A (en) 1998-10-13
EP0678524A1 (fr) 1995-10-25
WO1995012617A1 (fr) 1995-05-11
JP3517754B2 (ja) 2004-04-12
EP0678524B1 (fr) 2008-02-06
DE69435072D1 (de) 2008-03-20
AU8004394A (en) 1995-05-23
DE69435072T2 (de) 2009-01-29
ATE385506T1 (de) 2008-02-15
AU689147B2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
DK0678524T3 (da) Antistoffer mod oplöselig human fibrin, hybridom, der producerer dem, samt immunassayfremgangsmåde
NO955314L (no) Immunoanalyser for opplöselige fibrinpolymerer
FI954347L (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
AU5014196A (en) Monoclonal antibody reacting specifically with fas ligand and process for producing the same
EP0230934A3 (fr) Anticorps monoclonal, procédé de mesure de protéine glucosylée utilisant cet anticorps monoclonal, et trousse à cet effet
CA2089395A1 (fr) Anticorps monoclonaux pour detecter des polymeres de traitement de l'eau
EP0391433A3 (fr) Procédé pour l'essai, immunologique du complexe thrombine-antithrombine III, réactif pour l'essai et trousse
EP0287397A3 (en) Monoclonal antibody specific to human pancreatic phospholipase a2
NO954979L (no) Fremgangsmåte til sandwich immunoassay for N-peptid
DE69522021D1 (de) Monoklonaler Antikörper und seine Verwendung in einem Immunoassay
CA2054689A1 (fr) Une methode d'immunoessai pour determiner la specificite de liaison entre un anticorps monoclonal et un antigene
CA2075937A1 (fr) Anticorps diriges contre le complexe plasmine-.alpha.-2-inhibiteur de la plasmine humain, hybridomes et methode de determination immunologique
NO174005C (no) Monoklonalt antistoff, hybridom, og reagens for immunologisk analyse av x-hANP
DK329789D0 (da) Monoklonalt antistof
DE68917797D1 (de) Gegen menschliches Fibrinopepid A spezifische monoklonale Antikörper.
FI860937A0 (fi) Menetelmä ja reagenssi follikkelia stimuloivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
NO903820D0 (no) Fremgangsmaate for paavisning av analytter.
ZA861550B (en) Process and reagent for the determination of the luteinising hormone and monoclonal antibodies suitable therefor
EP0922761A4 (fr) Anticorps monoclonal specifique d'un monomere anti fibrine humaine, son procede d'obtention, hybridomes et procedes relatifs a des immuno-essais
AU2789297A (en) Novel monoclonal antibody and method of immunological analysis of e-D-dimer and e-DD/E complex
FR2743891B1 (fr) Procede pour l'identification ou le dosage immunologique d'antigenes polypeptidiques
KR890014129A (ko) 인간 psti를 인지하는 단클론성 항체, 항체를 생산하는 하이브리도마 및 인산 psti의 결정
JPS5386014A (en) Quantitative analysis of antigen and antibody
JPS6438654A (en) Immunoassay